Cite
HARVARD Citation
Prasad, M. et al. (2022). MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. Journal for immunotherapy of cancer. 10 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prasad, M. et al. (2022). MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. Journal for immunotherapy of cancer. 10 (3), p. . [Online].